Riskpilot← Back to searchSign inGet full accessOPTIKER BAKKETEIG OS AS
ASActiveOrg 899535812Øyro 17, 5200 OsRetail sale of medical and orthopaedic goods · NACE 4774Est. 20136 employees
Revenue 2024
NOK 8,4M
+12% vs 2023
EBITDA margin
12.1%
+58% vs 2023
Equity ratio
24.5%
Financial strength
Net profit 2024
NOK 772K
+57% vs 2023
| Revenue | NOK 8,4M | +12% |
| EBITDA | NOK 1M | +58% |
| Net profit | NOK 772K | +57% |
| Total assets | NOK 3,1M | +55% |
| Equity | NOK 760K | +56% |
| Employees | 6 | — |
Legal name
OPTIKER BAKKETEIG OS AS
Org number
899535812
Legal form
Aksjeselskap
NACE code
4774 · Retail sale of medical and orthopaedic goods
Founded
17. januar 2013
Share capital
NOK 30 000
Employees
6 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg.
Company purpose
Drive detaljhandel med optikk og alt som naturlig hører sammen med dette.
Address
Øyro 17, 5200 Os
Phone
+4756301800
Email
bakketeig.os@interoptik.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 6 920 | 7 488 | 6 910 | 7 494 | 8 412 |
| Staff expenses | −2 169 | −2 709 | −2 822 | −2 819 | −2 929 |
| EBITDA | 826 | 675 | 390 | 645 | 1 017 |
| Depreciation & amort. | −63 | −36 | −25 | −21 | −20 |
| EBIT | 763 | 640 | 364 | 624 | 997 |
| Net financials | −1 | −9 | −4 | −2 | −8 |
| Profit before tax | 762 | 631 | 360 | 622 | 989 |
| Tax | 174 | 127 | 75 | 131 | 218 |
| Net profit | 588 | 504 | 285 | 491 | 772 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 2 584 | 2 571 | 1 576 | 2 007 | 3 102 |
| Equity | 909 | 563 | 498 | 489 | 760 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1 675 | 2 008 | 1 078 | 1 518 | 2 342 |
| Total debt | 1 675 | 2 008 | 1 078 | 1 518 | 2 342 |
EBITDA margin
12.1%
This company
15.8%
Market median
-23% vs market
20202024
Equity ratio
24.5%
This company
38.2%
Market median
-36% vs market
20202024
Return on equity
101.5%
This company
18.4%
Market median
+452% vs market
20202024
Net profit margin
9.2%
This company
8.1%
Market median
+14% vs market
20202024
Asset turnover
2.71×
This company
1.12×
Market median
+142% vs market
20202024
Debt / equity
3.08×
This company
0.62×
Market median
-397% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
AC Chief Executive Officer | Chief Executive Officer | 2017 |
LS Deputy Member | Deputy Member | 2013 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2013 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Bakketeig Invest As
OPTIKER BAKKETEIG OS AS Board members of OPTIKER BAKKETEIG OS AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anette Chrisanthi Bakketeig | Chief Executive Officer | 0 companies |
| Linda Susan Bakketeig | Deputy Member | 0 companies |
| Andreas Bakketeig | Chairman | 0 companies |